Published in Cancer Res on October 15, 2007
Global transcriptome and deletome profiles of yeast exposed to transition metals. PLoS Genet (2008) 1.23
Genetic basis of arsenite and cadmium tolerance in Saccharomyces cerevisiae. BMC Genomics (2009) 1.07
Comparative functional genomic analysis identifies distinct and overlapping sets of genes required for resistance to monomethylarsonous acid (MMAIII) and arsenite (AsIII) in yeast. Toxicol Sci (2009) 0.97
Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers. Am J Pathol (2011) 0.95
A genome-wide screen in Saccharomyces cerevisiae reveals pathways affected by arsenic toxicity. Genomics (2009) 0.93
Mitogen-activated protein kinase Hog1 mediates adaptation to G1 checkpoint arrest during arsenite and hyperosmotic stress. Eukaryot Cell (2008) 0.83
Polymorphisms in maternal folate pathway genes interact with arsenic in drinking water to influence risk of myelomeningocele. Birth Defects Res A Clin Mol Teratol (2015) 0.76
SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell (2010) 5.40
Fluctuation analysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbruck fluctuation analysis. Bioinformatics (2009) 3.05
hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer (2005) 2.21
A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol Ther (2008) 2.03
Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer. Cancer Biol Ther (2006) 1.78
Mitochondrial dysfunction in cancer. Mitochondrion (2004) 1.77
Mitochondria and human cancer. Curr Mol Med (2007) 1.71
Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther (2005) 1.64
Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med (2002) 1.60
Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res (2005) 1.46
DNA replication stress is a determinant of chronological lifespan in budding yeast. PLoS One (2007) 1.46
Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. Nucleic Acids Res (2003) 1.44
p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog (2009) 1.43
NADPH oxidase 4 is an oncoprotein localized to mitochondria. Cancer Biol Ther (2010) 1.38
Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta (2010) 1.29
Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis (2003) 1.22
Meeting report: mitochondrial DNA and cancer epidemiology. Cancer Res (2007) 1.20
Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. Mol Cancer (2002) 1.16
Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin. PLoS One (2011) 1.16
Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. Cancer Biol Ther (2008) 1.15
Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol Ther (2009) 1.14
Is There a Link between Mitochondrial Reserve Respiratory Capacity and Aging? J Aging Res (2012) 1.08
Impaired OXPHOS complex III in breast cancer. PLoS One (2011) 1.07
Mitochondria as determinant of nucleotide pools and chromosomal stability. Mutat Res (2007) 1.05
Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus. Mutagenesis (2003) 1.01
Mitochondrial regulation of epigenetics and its role in human diseases. Epigenetics (2012) 0.98
Impairment of mitochondrial respiration in mouse fibroblasts by oncogenic H-RAS(Q61L). Cancer Biol Ther (2010) 0.98
NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injury. J Immunol (2013) 0.98
mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice. J Hum Genet (2009) 0.96
Loss of p53 function in colon cancer cells results in increased phosphocholine and total choline. Mol Imaging (2004) 0.93
Saccharomyces cerevisiae polymerase zeta functions in mitochondria. Genetics (2006) 0.91
Cellular stress induced by resazurin leads to autophagy and cell death via production of reactive oxygen species and mitochondrial impairment. J Cell Biochem (2010) 0.90
Cellular aging of mitochondrial DNA-depleted cells. Biochem Biophys Res Commun (2004) 0.90
Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone. Biochim Biophys Acta (2011) 0.89
The importance of mitochondrial DNA in aging and cancer. J Aging Res (2011) 0.88
A colony color method identifies the vulnerability of mitochondria to oxidative damage. Mutagenesis (2002) 0.88
Mitochondrial correlation microscopy and nanolaser spectroscopy - new tools for biophotonic detection of cancer in single cells. Technol Cancer Res Treat (2005) 0.87
Xenogenic transfer of isolated murine mitochondria into human rho0 cells can improve respiratory function. Rejuvenation Res (2007) 0.87
Systems biology approaches to evaluate arsenic toxicity and carcinogenicity: an overview. Int J Hyg Environ Health (2013) 0.85
Distinct functions of evolutionary conserved MSF1 and late embryogenesis abundant (LEA)-like domains in mitochondria. J Biol Chem (2011) 0.84
Illness-induced exacerbation of Leigh syndrome in a patient with the MTATP6 mutation, m. 9185 T>C. Mitochondrion (2010) 0.83
Reduced mitochondrial DNA content associates with poor prognosis of prostate cancer in African American men. PLoS One (2013) 0.81
Natural selection of mitochondria during somatic lifetime promotes healthy aging. Front Neuroenergetics (2013) 0.79
Evaluation of cell types for assessment of cytogenetic damage in arsenic exposed population. Mol Cancer (2008) 0.79
Arsenic-induced health effects and genetic damage in keratotic individuals: involvement of p53 arginine variant and chromosomal aberrations in arsenic susceptibility. Mutat Res (2007) 0.76
Mitochondrial inhibition of uracil-DNA glycosylase is not mutagenic. Mol Cancer (2004) 0.75